Metals Creek Resources Corp. (TSXV: MEK) (FSE: M1C1) (the "Company" or Metals Creek) is pleased to announce the discovery of ...
Al-Monitor is an award-winning media outlet covering the Middle East, valued for its independence, diversity and analysis. It is read widely by US, international and Middle East decision makers at the ...
The FDA has approved an oral, small molecule MEK inhibitor for adult and pediatric patients 2 years of age and older with ...
A new policy has been long overdue. After the People’s Mojahedin Organization of Iran (PMOI/MEK), exposed the first key details of Tehran’s clandestine nuclear weapons program in 2002.
SpringWorks Therapeutics (SWTX) has announced that the U.S. Food and Drug Administration has approved GOMEKLI, a small molecule MEK inhibitor, for the treatment of adult and pediatric patients 2 years ...
Phase II study of niraparib and dostarlimab for the treatment of germline or somatic homologous recombination repair mutated (HRD) metastatic pancreatic cancer.
The new Mek PowerSpector JSAz 550 desktop AOI system features a completely redesigned chassis, including upgraded motors, drives, and spindles. While the optics and software remain consistent with MEK ...
February 19, 2025) - Metals Creek Resources Corp. (TSXV: MEK) (FSE: M1C1) (the "Company" or Metals Creek) is pleased to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback